What does Revolution Medicines, Inc. do?
Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in…
What is Revolution Medicines, Inc.'s P/E and P/B ratio?
Revolution Medicines, Inc. has a P/E ratio of -21.2 and a P/B ratio of 15.44.
What is Revolution Medicines, Inc.'s debt-to-equity ratio?
Revolution Medicines, Inc. has a debt-to-equity ratio of 0.46.
How much does Revolution Medicines, Inc. owe compared with what it owns?
Revolution Medicines, Inc. owes $0.40 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Revolution Medicines, Inc.'s Positivity rank?
Revolution Medicines, Inc. is ranked #6,027 of 6,774 companies globally and #3,401 of 4,000 in United States on PositoAI, with a Positivity Score of 11,695.
Does Revolution Medicines, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Revolution Medicines, Inc..
Where can I read the latest news about Revolution Medicines, Inc.?
Recent headlines about Revolution Medicines, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Revolution Medicines, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Revolution Medicines, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.